Heart Failure Improvement with CoQ10, Hawthorn, and Magnesium in a Patient Scheduled for Cardiac Resynchronization-Defibrillator Therapy: A Case Study

Explore: The Journal of Science and Healing

Volumn 2, Issue 4, 2006, Pages 339-341

  Islam, Jamal ^a   Uretsky, Barry F ^a   Sierpina, Victor S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CRATAEGUS EXTRACT; CYANOCOBALAMIN; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FISH OIL; FOLIC ACID; GLYCERYL TRINITRATE; HERBACEOUS AGENT; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LINSEED OIL; MAGNESIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PYRIDOXINE; SILDENAFIL; UBIDECARENONE; WARFARIN;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; CORONARY ARTERY OBSTRUCTION; DEFIBRILLATION; DRUG SUBSTITUTION; ELECTROCARDIOGRAPHY; ERECTILE DYSFUNCTION; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HOLISTIC CARE; HUMAN; HYPERTENSION; INTRACARDIAC THROMBOSIS; MALE; OSTEOARTHRITIS; PATIENT SCHEDULING; PRIORITY JOURNAL; TRADITIONAL MEDICINE; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTIOXIDANTS; CARDIAC OUTPUT, LOW; COENZYMES; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; TREATMENT OUTCOME; UBIQUINONE;

EID: 33745897932     PISSN: 15508307     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.explore.2006.05.011     Document Type: Article

References (20)

1. American Heart Association. Heart Disease and Stroke Fact, 2004 (2004), Dallas AHA, Dallas
2. Bristow M., Saxon L., Boehmer J., et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrilator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
3. Cleland J., Daubert J., Erdmann E., et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
4. Leshadri N., and Robinson K. Homocysteine, B vitamins and coronary artery disease. Med Clin N Am 84 (2000) 215-237
5. Desai A.S., Fang J.C., Maisel W.H., and Baughman K.L. Implantable defibrillators for the prevention of mortality in patients with non-ischemic cardiomyopathy. a meta-anlaysis of randomized controlled trials. JAMA 292 (2004) 2874-2879
6. Weihmyar T., and Ernst E. Therapeutic effectiveness of Cartaegus. Fortschr Med 1996 (1996) 27-29
7. Schimidt U., Kuhn U., Ploch M., et al. Efficacy of the hawthorn abstract LI 132 (600 mg/d) during eight week's treatment. Munch Med Wocensher 132 (1994) 513-519
8. Weiki V.A., Assimus K.D., Neukum-Schimdt A., et al. Objective confirmation of the efficacy if a special Crategus W 1442 in patients with cardiac insufficiency (NYHA II). [German]. Fortschr Med 114 (1994) 291-296
9. Bharani A., Ganguly A., and Bhargava K.D. Salutary effect of Terminalia arjuna in pateints with severe refractory heart failure. Int J Cardiol 49 (1995) 191-199
10. Ding D.Z., Shen T.K., and Cui Y.Z. The effects of red ginseng on congestive heart failure and its mechanism. Chung Kuo Ching Hsi I Chieh Ho Ysa Chih 15 (1995) 325-327
11. Chen H.C., and Hsieh M.T. Hemodynamic effects of orally administered Sunitang in humans. Clin Pharmacol Ther 41 (1987) 496-501
12. Berman M., Erman A., Ben-Gal T., et al. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation. a randomized, placebo-controlled study. [see comment]. Clin Cardiol 27 (2004) 295-299
13. Rector R.S., Bank A.J., and Mullen K.A. Randomized, double-blind, placebo-controlled study of supplement oral L-arginine in patients with heart failure. Circulation 1996 (1996) 2135-2141
14. Zhou J.R. Effect of auriculo-acupuncture plus needle embedding in heart point on left cardiac, humoral and endocrine function. Chung Kuo Ching Hsi I Chieh Ho Ysa Chih 13 (1993) 153-154
15. Qian L., Zhou Q., Wang Z., Huang J., and Yi F. Effects of Qigong Waiqi on hemodynamics and left ventricular systolic function in patients with congestive heart failure. Bull Hunan Med University 18 (1993) 397-399
16. Hood W.B.J., Dans A.L., Guyatt G., Jaeschke R., and McMurray J.J.V. Digitalis for treatment of congestive heart failure in patients in sinus rhythm (Cochrane Review) (2004), John Wiley and Sons, Ltd, Chichester, UK
17. Rosenfeldt F., Hilton D., Pepe S., and Krum H. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors 18 (2003) 91-100
18. Bashir Y., Sneddon J.F., Staunton H.A., et al. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol 72 (1993) 1156-1162
19. Dec G., Palacios I., Fallon J., et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. N Engl J Med 12 (1985) 855-980
20. Steimle A.E., Stevenson L., Fonrow G., et al. Prediction of improvement in recent onset cardiomypathy after referral for heart transplantation. J Am Coll Cardiol 23 (1994) 553-559